[{"Assets_0_Q2_USD":54226000.0,"CommonStockSharesOutstanding_0_Q2_shares":17998420.0,"EarningsPerShareBasic_1_Q2_USD":-0.41,"EarningsPerShareBasic_2_Q2_USD":-0.83,"EarningsPerShareDiluted_1_Q2_USD":-0.41,"EarningsPerShareDiluted_2_Q2_USD":-0.84,"NetIncomeLoss_1_Q2_USD":-7380000.0,"NetIncomeLoss_2_Q2_USD":-14897000.0,"StockholdersEquity_0_Q2_USD":50452000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":18015748.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":17995109.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":17997194.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":17971702.0,"Ticker":"XENE","CIK":"1582313","name":"XENON PHARMACEUTICALS INC.","OfficialName":"Xenon Pharmaceuticals Inc. Common Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1764405075.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]